A core facility for analyzing gene variants related to epilepsy
Gene Variant Curation Core (GVCC)
This study is looking at how certain gene changes might affect epilepsy, and it's creating a tool to help doctors figure out if these changes are harmful or not, which could lead to better testing and treatment for patients with epilepsy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10873150 on NIH RePORTER |
What this research studies
The Gene Variant Curation Core (GVCC) focuses on analyzing genetic variants associated with epilepsy by integrating genetic data from various patient cohorts and population databases. It aims to develop a computational model called EpiPred, which will help predict whether specific gene variants are harmful or benign. This project involves collaboration among multiple prestigious universities and utilizes advanced prediction tools and structural modeling to enhance the understanding of genetic contributions to epilepsy. Patients may benefit from improved genetic testing and personalized treatment options based on the findings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with epilepsy or those who have a family history of epilepsy and are undergoing genetic testing.
Not a fit: Patients without epilepsy or those not undergoing genetic testing may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate genetic testing for epilepsy, allowing for better-targeted treatments.
How similar studies have performed: Similar research efforts have shown promise in improving genetic understanding and treatment of epilepsy, indicating a potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Carvill, Gemma Louise — University of Michigan at Ann Arbor
- Study coordinator: Carvill, Gemma Louise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.